About the Studies
This study is designed to evaluate the safety and effectiveness of potential new treatment options looking reducing the number of moderate to severe exacerbations in adults with COPD. Participants could receive the study medication and a rescue medication during the study at no cost.
The studies are randomized, double-blind, and placebo-controlled to ensure high-quality, unbiased results. If you qualify and choose to participate, there is a chance you will receive a placebo. A placebo is an inactive material that looks like the study medications but does not contain any active ingredient.
The study durations vary depending on which one you qualify for, but will include a combination of in-clinic and telehealth visits. If you qualify and choose to participate, you will be compensated for your study-related time and travel. Your participation is entirely voluntary, and you can leave the study at any time.